Thursday, 14 June 2012

Breast Cancer Drugs-The Sentinel Lymph-Promising Drugs

Older Drug for Advanced Breast Cancer Beat Newer, Pricier Meds

Study found Taxol outperformed Abraxane, Ixempra in terms of survival and side effects (Source: Cancercompass News: Breast Cancer)MedWorm Sponsor Message: Have a look at The Breast Cancer Daily, the new breast cancer portal with all the latest breast cancer news and research powered by MedWorm, updated daily. read more..

The positive non-sentinel status is not the main decisional factor for chemotherapy assignment in breast cancer with micrometastatic disease in the sentinel lymph node

ConclusionHigh tumor grade is the main decisional factor followed by HER2 positivity and then by the positive non-SN status for CT in micrometastatic disease in the SN. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology) read more..

FDA to let women try new breast cancer drugs earlier

CHICAGO (Reuters) - Regulators are moving the goal posts in testing new drugs for breast cancer in the hopes of giving more women with aggressive, early-stage cancers the chance to try promising drugs while they have the best shot at a cure. (Source: Modern Medicine) read more..

1 comment:

  1. This is actually to boot the most fantastic post we tend to earnestly veteran researching throughout. It happens to be definitely not consistently we've found financial risk view a little. Medicines